Epilepsy
Conditions
Keywords
Epilepsy, Tracking, Electronic diary
Brief summary
The investigators propose a novel method for tracking the seizure frequency, side effect burden, and medication compliance for patients with epilepsy. The investigators intend to utilize a table-top device currently for tracking other chronic disease to collect remote data from epilepsy patients. The hypothesis is that the use of this device will lead to better longterm treatment outcomes than the standard outpatient mechanism of following patients longitudinally.
Interventions
DEVICEHealthBuddy
Noninvasive device for remotely reporting health information. The device does nothing to change the health of the patient, but transmits health data that is entered by the patient directly to the physician's office. Patients will enter data on seizure frequency, medication compliance, and side effects.
Sponsors
San Francisco Veterans Affairs Medical Center
University of California, San Francisco
Study design
Observational model
OTHER
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
6 Months to 65 Years
Healthy volunteers
No
Inclusion criteria
* Eligible participants must have a definitive diagnosis of epilepsy for at least 6 months, based on the clinical judgement of the investigators. Epilepsy is defined by two or more unprovoked seizures. Clinical history, electroencephalography, and imaging data are all instrumental in rendering a formal decision. The seizure type, frequency, or severity are not criteria for exclusion, although this information will be recorded. Patient can range in age from birth to 65 years old; in cases of child participants, the parents are responsible for data reporting. * Patients must have a seizure frequency of at least two seizures in a 6 month period of time. * Patients must be on at least one anti-epileptic medication. * Patients and/or legal guardian must be able to report seizure frequency with either a paper or electronic diary. * Patients and/or legal guardians must be able to read and understand either English or Spanish. * Patients and/or legal guardians must be able to complete questionnaires and provide informed consent to this study.
Exclusion criteria
*
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Seizure frequency per month | 1 year | Assessment of seizure count accuracy by assessing total number of seizures reported per month |
| Medication compliance | 1 year | Assessment of compliance with taking medications at regularly scheduled intervals |
| Quality of life | 1 year | Quality of Life in Epilepsy inventory, to assess for overall change in quality of life measures |
Countries
United States
Outcome results
None listed